Science & Health
York-based Cizzle Biotechnology receives US clinical accreditation for lung cancer blood test
A blood test developed by York-based Cizzle Biotechnology to detect early-stage lung cancer has been accredited for clinical use in the US. The test identifies the CIZ1B biomarker and is now moving from development to c…